دورية أكاديمية

Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study.

التفاصيل البيبلوغرافية
العنوان: Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study.
المؤلفون: del Río-Garma, Julio, Alvarez-Larrán, Alberto, Martínez, Clara, Muncunill, Josep, Castell, Dolors, de la Rubia, Javier, Zamora, Concepción, Corral, Mercedes, Viejo, Aurora, Peña, Francisco, Rodríguez-Vicente, Pilar, Contreras, Enric, Arbona, Cristina, Ramírez, Consuelo, Garcia-Erce, José A., Alegre, Adrián, Mateo, Jos, Pereira, Arturo
المصدر: British Journal of Haematology; Oct2008, Vol. 143 Issue 1, p39-45, 7p, 3 Charts
مصطلحات موضوعية: THROMBOTIC thrombocytopenic purpura, HEMOLYTIC anemia, PLASMA exchange (Therapeutics), BLOOD transfusion, COMMUNICABLE diseases, BLOOD plasma
مستخلص: Plasma exchange (PE) with plasma infusion is the treatment of choice for thrombotic thrombocytopenic purpura (TTP) but doubts remain as to whether all kinds of plasma are equally effective. A multicentric cohort study was conducted to compare methylene blue-photoinactivated plasma (MBPIP) with quarantine fresh frozen plasma (qFFP) in the treatment of TTP. One hundred and two episodes of idiopathic TTP were included; MBPIP was used in 63 and qFFP in 39. The treatment schedule consisted of daily PE and costicosteroids, and the main end-point was remission status on day 8. Patients treated with MBPIP required more PEs (median: 11 vs. 5, P = 0·002) and a larger volume of plasma (median: 485 ml/kg vs. 216 ml/kg, P = 0·007) to achieve a remission, and presented more recrudescences while on PE therapy (29 of 63 vs. 8 of 39, P = 0·02) than those receiving qFFP. After adjustment for possible confounding factors, the use of MBPIP was associated with a lower likelihood of remission on day 8 [Odds ratio (OR): 0·17; 95% confidence interval (CI): 0·06–0·47] and a higher risk of recrudescence while on treatment (OR: 4·2; 95% CI: 1·6–10·8). In conclusion, MBPIP is less effective than qFFP in the treatment of TTP. [ABSTRACT FROM AUTHOR]
Copyright of British Journal of Haematology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00071048
DOI:10.1111/j.1365-2141.2008.07292.x